Word

ULREMEV

Status

Registered

Status Code

700

Status Date

Tuesday, May 5, 2020

Serial Number

79272946

Registration Number

6044746

Registration Date

Tuesday, May 5, 2020

Mark Type

4000

Filing Date

Tuesday, October 8, 2019

Published for Opposition

Tuesday, February 18, 2020

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Trademark Events

Aug 11, 2023

Change Of Name/Address Rec'd From Ib

Jul 24, 2020

Notification Processed By Ib

Jul 9, 2020

Final Disposition Notice Sent To Ib

Jul 9, 2020

Final Disposition Processed

Jun 4, 2020

Grant Of Protection Created, To Be Sent To Ib

May 5, 2020

Registered-Principal Register

Feb 18, 2020

Published For Opposition

Jan 29, 2020

Notice Of Publication

Jan 14, 2020

Assigned To Lie

Jan 13, 2020

Approved For Pub - Principal Register

Jan 13, 2020

Assigned To Examiner

Dec 7, 2019

Application Filing Receipt Mailed

Dec 3, 2019

New Application Office Supplied Data Entered

Dec 2, 2019

Limitation From Original Application Entered

Nov 28, 2019

Sn Assigned For Sect 66a Appl From Ib